JP5851240B2 - マスカダイン搾りかす抽出物の調製方法 - Google Patents

マスカダイン搾りかす抽出物の調製方法 Download PDF

Info

Publication number
JP5851240B2
JP5851240B2 JP2011521346A JP2011521346A JP5851240B2 JP 5851240 B2 JP5851240 B2 JP 5851240B2 JP 2011521346 A JP2011521346 A JP 2011521346A JP 2011521346 A JP2011521346 A JP 2011521346A JP 5851240 B2 JP5851240 B2 JP 5851240B2
Authority
JP
Japan
Prior art keywords
muscadine pomace
extract
pomace extract
copper
muscadine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2011521346A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011529909A5 (enExample
JP2011529909A (ja
Inventor
ティー アイアニロ テオドロ
ティー アイアニロ テオドロ
エイ フィッシャー ローレル
エイ フィッシャー ローレル
ジェイ メルゲンス ウィリアム
ジェイ メルゲンス ウィリアム
Original Assignee
シャクリー コーポレーション
シャクリー コーポレーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シャクリー コーポレーション, シャクリー コーポレーション filed Critical シャクリー コーポレーション
Publication of JP2011529909A publication Critical patent/JP2011529909A/ja
Publication of JP2011529909A5 publication Critical patent/JP2011529909A5/ja
Application granted granted Critical
Publication of JP5851240B2 publication Critical patent/JP5851240B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
JP2011521346A 2008-07-31 2009-07-31 マスカダイン搾りかす抽出物の調製方法 Active JP5851240B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8537108P 2008-07-31 2008-07-31
US61/085,371 2008-07-31
PCT/US2009/052346 WO2010014873A2 (en) 2008-07-31 2009-07-31 Method of preparing a muscadine pomace extract

Publications (3)

Publication Number Publication Date
JP2011529909A JP2011529909A (ja) 2011-12-15
JP2011529909A5 JP2011529909A5 (enExample) 2015-07-09
JP5851240B2 true JP5851240B2 (ja) 2016-02-03

Family

ID=41610969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011521346A Active JP5851240B2 (ja) 2008-07-31 2009-07-31 マスカダイン搾りかす抽出物の調製方法

Country Status (7)

Country Link
US (2) US8512771B2 (enExample)
JP (1) JP5851240B2 (enExample)
CN (2) CN102164607B (enExample)
CA (1) CA2732426C (enExample)
MX (1) MX2011001183A (enExample)
MY (1) MY158981A (enExample)
WO (1) WO2010014873A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132162B2 (en) * 2008-07-31 2015-09-15 Shaklee Corporation Muscadine compositions with anti-oxidant activity
CA2732426C (en) * 2008-07-31 2018-05-15 Shaklee Corporation Method of preparing a muscadine pomace extract
US9173916B2 (en) * 2008-07-31 2015-11-03 Shaklee Corporation Method of preparing a muscadine pomace extract
CA2904636C (en) * 2013-03-14 2021-05-04 Shaklee Corporation Method of preparing a muscadine pomace extract
US20160067298A1 (en) * 2014-09-10 2016-03-10 Clark Atlanta University Muscadine grape skin extract as treatment for bone metastatic cancer
US9579618B2 (en) 2015-06-17 2017-02-28 Christos Ritzoulis Emulsifiers from grape processing by-products
ES2644166B1 (es) * 2016-05-24 2018-09-24 Universitat Politécnica de Catalunya Procedimiento para la obtención de un extracto tánico aislado de uva, extracto tánico obtenido y sus usos
CN109641024B (zh) * 2016-07-19 2022-03-25 嘉康利公司 具有低含量缩合鞣质分子的麝香葡萄局部组合物
US20180325804A1 (en) * 2017-05-12 2018-11-15 Shaklee Corporation Topical muscadine formulation for cosmetic use
IT201700081175A1 (it) * 2017-07-18 2019-01-18 Nobil Bio Ricerche Srl Dispositivi implantari rivestiti
CN107691927A (zh) * 2017-11-06 2018-02-16 北京市农林科学院 一种打瓜的综合利用方法
US11103465B2 (en) * 2017-11-22 2021-08-31 Ted's Brain Science, Inc. Trans-resveratrol topical medication for the treatment of pain and method of manufacture thereof
CA3054498C (en) * 2017-12-15 2022-08-02 Tsukasa Nagao Health food and cosmetics for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells and a method of manufacturing a sprout-forcing grape seed-derived ingredient for increasing the amount of apoptosis cells and decreasing the amount of necrosis cells
IT202000006493A1 (it) * 2020-03-27 2021-09-27 Ngn Healthcare New Generation Nutraceuticals S R L Integratore alimentare per contrastare la degenerazione maculare legata all’eta’

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2318511A (en) 1996-10-23 1998-04-29 Eurand Int Process for the preparation of a pharmaceutical composition for rapid suspension in water
US6190716B1 (en) 1999-02-17 2001-02-20 Scott O. Galbreath, Jr. Method for preparing a grape derived product
FR2790645B1 (fr) 1999-03-12 2001-06-08 Arkopharma Laboratoires Complement alimentaire et procede de traitement cosmetique a base d' un extrait de raisin riche en polyphenols
CN1137985C (zh) * 2001-02-27 2004-02-11 中法合营王朝葡萄酿酒有限公司 一种干白葡萄酒及其勾兑工艺
JP2002293736A (ja) * 2001-03-30 2002-10-09 Sunstar Inc メーラード反応阻害剤およびそれを含有する組成物
US20040234671A1 (en) * 2003-05-20 2004-11-25 Ector Betty J. Houston Method and system for processing muscadine grape pomace
US20050158376A1 (en) * 2003-10-23 2005-07-21 Sardi William F. Dietary supplement and method of processing same
JP4963670B2 (ja) 2004-04-07 2012-06-27 レスベラトロル パートナーズ， エルエルシー 栄養補助サプリメントおよびそれを処理する方法
US20060024392A1 (en) * 2004-04-20 2006-02-02 The University Of Maryland Compositions and methods for enhancing the effectiveness of a chemotherapeutic agent
US20060121137A1 (en) 2004-12-07 2006-06-08 Hartle Diane K Muscadine grape pomace in the treatment of intestinal inflammation
US8182849B2 (en) 2005-02-23 2012-05-22 Otsuka Pharmaceutical Co., Ltd. Fermented tea beverage and tea beverage
WO2006113700A1 (en) * 2005-04-16 2006-10-26 Unitel Technologies, Inc. Concentrated polyphenolic product and process for making the same
US20060277887A1 (en) * 2005-05-31 2006-12-14 Nutragon, Llc Method for processing organic plant matter into dry powder, oil and juice products
CN1698733A (zh) 2005-06-02 2005-11-23 陕西爱波卓科技有限责任公司 一种含多种抗氧化剂及抗氧化剂促进剂的抗氧化组合物
ES2542713T3 (es) 2005-09-28 2015-08-10 Constellation Brands, Inc. Extracto de uva, suplemento en la dieta del mismo y procedimiento de preparación
JP2009521523A (ja) 2005-12-27 2009-06-04 ジュビラント・オルガノシス・リミテッド 口中溶解性医薬組成物およびその製造方法
US8017147B2 (en) 2008-04-07 2011-09-13 Mazed Mohammad A Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
KR20100014799A (ko) 2007-01-17 2010-02-11 엔베쎄 뉴트라쇠틱 비지니스 컨썰팅 과일 및 야채를 함유하는 항산화 음식조성물, 그 제조 방법 및 용도
WO2008144019A2 (en) 2007-05-18 2008-11-27 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Suppression of allergic inflammation by ascaris heme-binding protein (hbp)
US20090176718A1 (en) 2007-10-31 2009-07-09 David Ribnicky Berry Preparations For Treatment Of Diabetes And Metabolic Syndrome
US9173916B2 (en) * 2008-07-31 2015-11-03 Shaklee Corporation Method of preparing a muscadine pomace extract
CA2732426C (en) * 2008-07-31 2018-05-15 Shaklee Corporation Method of preparing a muscadine pomace extract
CA2732306C (en) * 2008-07-31 2017-02-28 Shaklee Corporation Muscadine compositions with improved anti-oxidant activity
US9132162B2 (en) * 2008-07-31 2015-09-15 Shaklee Corporation Muscadine compositions with anti-oxidant activity
US8114445B2 (en) 2008-11-07 2012-02-14 Reliv International Inc. Dietary supplement for promoting wellness and weight loss and methods of administering the same
US8173181B2 (en) 2009-11-09 2012-05-08 Bio-Engineered Supplements & Nutrition, Inc. Method and composition for improved anabolism

Also Published As

Publication number Publication date
US9421189B2 (en) 2016-08-23
JP2011529909A (ja) 2011-12-15
WO2010014873A3 (en) 2010-05-06
CN103623135B (zh) 2015-12-09
US8512771B2 (en) 2013-08-20
CA2732426C (en) 2018-05-15
MY158981A (en) 2016-11-30
US20130303603A1 (en) 2013-11-14
US20110177183A1 (en) 2011-07-21
CN102164607A (zh) 2011-08-24
MX2011001183A (es) 2011-03-30
CN103623135A (zh) 2014-03-12
CN102164607B (zh) 2013-04-24
CA2732426A1 (en) 2010-02-04
WO2010014873A2 (en) 2010-02-04
HK1190328A1 (zh) 2014-07-04

Similar Documents

Publication Publication Date Title
JP5608646B2 (ja) 向上した抗酸化活性を有するマスカダイン組成物
JP5851240B2 (ja) マスカダイン搾りかす抽出物の調製方法
CN102458155B (zh) 具有改善的生物利用度的绿茶提取物
US9132162B2 (en) Muscadine compositions with anti-oxidant activity
US9173916B2 (en) Method of preparing a muscadine pomace extract
US20160331798A1 (en) Natural product inhibitors of 3dg
JP6445518B2 (ja) マスカダインポマース抽出物の調製方法
TWI448250B (zh) 具有改良的抗氧化劑活性的麝香葡萄組成物
CN104812253B (zh) 用具有低血糖指数的碳水化合物增加黄烷-3-醇的生物利用度
HK1190328B (en) Method of preparing a muscadine pomace extract

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120703

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131029

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140129

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140205

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20141125

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150217

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20150421

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20150519

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20150818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151015

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20151110

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20151202

R150 Certificate of patent or registration of utility model

Ref document number: 5851240

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250